Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of BML, INC.. A complete text table follows the diagram.
Revenue rose 6.0% and operating profit 14.4% even after the new BML General Laboratory increased depreciation.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Clinical testing & related gross profit | 1 | 25.2B | 100.0% of reported total |
| Gross profit | 2 | 25.2B | Reported profit after direct testing and service costs |
| Operating profit | 3 | 5.9B | Reported consolidated operating profit after overhead |
| Selling, laboratory & administrative overhead | 3 | 19.2B | Personnel, supplies, new-laboratory depreciation and other operating overhead |
| Profit before tax | 4 | 6.6B | Reported pretax result |
| Property sale, dividends & other income, net | 3 | 709M | JPY539M property-sale gain plus dividends and other income, net of interest, property costs and JPY33M extraordinary loss |
| Net profit attributable to owners | 5 | 4.2B | Reported parent-company result |
| Tax, attribution & other | 5 | 2.4B | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Clinical testing & related gross profit | Gross profit | 25.2B |
| Gross profit | Operating profit | 5.9B |
| Gross profit | Selling, laboratory & administrative overhead | 19.2B |
| Operating profit | Profit before tax | 5.9B |
| Property sale, dividends & other income, net | Profit before tax | 709M |
| Profit before tax | Net profit attributable to owners | 4.2B |
| Profit before tax | Tax, attribution & other | 2.4B |